首页 产品目录 分子砌块 按反应类型 五元杂环胺化 N1-((S)-1-(((S)-1-((2-aminoethyl)amino)-1-oxopropan-2-yl)amino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)-N4-hydroxy-2-isobutylsuccinamide

N1-((S)-1-(((S)-1-((2-aminoethyl)amino)-1-oxopropan-2-yl)amino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)-N4-hydroxy-2-isobutylsuccinamide

N1-((S)-1-(((S)-1-((2-aminoethyl)amino)-1-oxopropan-2-yl)amino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)-N4-hydroxy-2-isobutylsuccinamide

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
1mg 95% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

171235-71-5

英文名称

N1-((S)-1-(((S)-1-((2-aminoethyl)amino)-1-oxopropan-2-yl)amino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)-N4-hydroxy-2-isobutylsuccinamide

别名

N1-((S)-1-((S)-1-(2-aminoethylamino)-1-oxopropan-2-ylamino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)-N4-hydroxy-2-isobutylsuccinamide;N-[2-[2-(Hydroxyamino)-2-oxoethyl]-4-methyl-1-oxopentyl]-3-(2-naphthalenyl)-L-alanyl-N-(2-aminoethyl)-L-alaninamide;N-[2-[2-(Hydroxyamino)-2-oxoethyl]-4-methyl-1-oxopentyl]-3-(2-naphthalenyl)-L-alanyl-N-(2-aminoethyl)-L-alaninamide TAPI-1;TNF-Α PROTEASE INHIBITOR-1 (TAPI-1);TAPI-1 trifluoroacetate;2-aminoethyl Amide;N-(R)-[2-(Hydroxyaminocarbonyl)methyl]-4-methylpentanoyl-L-naphthylalanyl-L-alanine;N-(R)-[2-(HYDROXYAMINOCARBONYL)METHYL]-4-METHYLPENTANOYL-L-NAPHTHYLALANYL-L-ALANINE; 2-AMINOETHYL AMIDE; TNF-Α PROTEASE INHIBITOR-1

标准英文名

N1-((S)-1-(((S)-1-((2-aminoethyl)amino)-1-oxopropan-2-yl)amino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)-N4-hydroxy-2-isobutylsuccinamide

分子式

C26H37N5O5

分子量

499.61

精确分子量

499.28

SMILES

CC(C)CC(CC(=O)NO)C(=O)N[C@@H](CC1=CC=C2C=CC=CC2=C1)C(=O)N[C@@H](C)C(=O)NCCN

标准SMILES

CC(C)CC(CC(=O)NO)C(=O)N[C@@H](CC1C=C2C=CC=CC2=CC=1)C(=O)N[C@@H](C)C(=O)NCCN

用途

TAPI-1 is an ADAM17/TACE inhibitor that suppresses the release of soluble TNF-alpha, p60TNFR, and IL-6R from unstimulated and PMA-induced monocytic cell lines (e.g., THP-1) and human peripheral blood mononuclear cells; it inhibits TACE-dependent constitutive shedding of co-transfected APP(695); attenuates AngII-induced EGFR transactivation and cell proliferation in the human hematopoietic stem cell line LI90; and, in combination with the EGFR inhibitor AG1478, inactivates the AREG/EGFR/ERK signaling pathway and reduces pro-inflammatory cytokine release in pSS salivary gland-derived epithelial cells. TAPI-1 also acts as a Matrix Metalloproteinase (MMP) inhibitor.

InChIKey

AWNBSWDIOCXWJW-OWHMDLSXSA-N

安全信息

SureRoute逆合成路线

1.  171235-71-5 逆合成路线 1

—
—
ACHDTM105
171235-71-5
来源: SureRoute

2.  171235-71-5 逆合成路线 2

—
—
—
—
ACHDTM105
171235-71-5
来源: SureRoute

3.  171235-71-5 逆合成路线 3

—
—
ACHDTM105
171235-71-5
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手